DR. NAOTO HIRANO

DR. NAOTO HIRANO

ASSOCIATE DIRECTOR, RESEARCH, TUMOR IMMUNOTHERAPY PROGRAM

For Dr. Naoto Hirano, the true value of research occurs when it can be translated into making a difference in patients’ lives. 

To him, that is the beauty of Princess Margaret Cancer Centre. He and his team aim to turn discoveries into practical solutions for patients and make adoptive T-cell therapy available for every cancer patient who could benefit. His research aims to invent new and personalized anti-tumor immunotherapeutic models that can cure cancer.

Dr. Hirano attended medical and graduate school at the University of Tokyo. He was an assistant professor at the Dana-Farber Cancer InstituteHarvard Medical School, before joining The Princess Margaret five years ago.


IMMUNOTHERAPY


THE CANCER WARRIOR UNLEASHED
Special feature publication. Read it online now or order a free magazine.
ORDER FREE COPY
READ ONLINE